FDA approves GSK's Priorix vaccine for measles, mumps and rubella - PMLiVE

6/8/2022 12:00:00 AM2 years 11 months ago

The vaccine has been approved to use in those aged 12 months and above

GlaxoSmithKline (GSK) has announced that it has received approval from the US Food and Drug Administration (FDA) for Priorix, a live measles, mumps and rubella (MMR) vaccine. The vaccine can be used … [+2404 chars]

full article...